Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
Take action
Contact the company
📍Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer
Fresenius Kabi USA, LLC is recalling a specific quantity of Rifampin for Injection, USP 600mg/vial because the product failed impurity and degradation specifications. The affected vials may have out-of-specification color or impurity levels. This recall affects 7,593 vials distributed nationwide, including Hawaii and Puerto Rico. Read more at govinfonow.com/recall/44206-fresenius-kabi-usa-llc-recalls-rifampin-for-injection-usp-600mg.
“Fresenius Kabi Recalls Rifampin for Injection Due to Impurities.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44206-fresenius-kabi-usa-llc-recalls-rifampin-for-injection-usp-600mg. Based on FDA recall #D-1234-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1234-2015%22&limit=1).
The FDA announced on June 4, 2015, that Fresenius Kabi USA, LLC voluntarily recalled Rifampin for Injection due to failed impurity and degradation specifications. The recall affects 7,593 vials distributed nationwide, in Hawaii, and Puerto Rico.
How to tell if you have it
Brand: Fresenius Kabi
Product: Rifampin for Injection, USP 600mg/vial in a 20mL vial
NDC: 63323-351-20
Lot codes: 6109469, 6109470
Expiration date: 10/2016
The hazard
The product is out-of-specification for color, impurity, and degradation. The recall was classified as a Class II recall.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has had 65 other recalls on record since September 27, 2012. Recent recalls include the August 10, 2026 Tyenne Injection recall for glass particles and the August 4, 2026 Morphine Syringes recall for wrong labeling. Other recent recalls of similar products include the March 3, 2026 Temozolomide capsules recall due to impurity issues and the September 18, 2026 Fosfomycin Tromethamine Granules recall due to impurities.
How to tell if you have this one
Look for Rifampin for Injection, USP 600mg/vial in a 20mL vial. Check for NDC 63323-351-20 and Lot numbers 6109469 or 6109470 with an expiration date of 10/2016.
Brand
Fresenius Kabi
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check lot numbers
Verify if your vials match Lot numbers 6109469 or 6109470 with an expiration date of 10/2016.
Contact provider
If you have the recalled lots, contact your healthcare provider or pharmacist for instructions on what to do next.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide,Hawaii, and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1234-2015 (June 4, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1234-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.